BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6738408)

  • 1. Therapeutics of hyperuricaemia and gout.
    Emmerson BT
    Med J Aust; 1984 Jul; 141(1):31-6. PubMed ID: 6738408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug control of gout and hyperuricaemia.
    Emmerson BT
    Drugs; 1978 Aug; 16(2):158-66. PubMed ID: 352666
    [No Abstract]   [Full Text] [Related]  

  • 3. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milestones in the treatment of gout.
    Yü T; Yu TF
    Am J Med; 1974 May; 56(5):676-85. PubMed ID: 4604776
    [No Abstract]   [Full Text] [Related]  

  • 5. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gout.
    JAMA; 1973 Apr; 224(5 Suppl):757-66. PubMed ID: 4349285
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug treatment of gout.
    Kelley WN; Wyngaarden JB
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
    Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
    Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of gout.
    Kersley GD
    Scott Med J; 1973; 18():Suppl 1:249-50. PubMed ID: 4773968
    [No Abstract]   [Full Text] [Related]  

  • 10. The management of gout.
    Emmerson BT
    N Engl J Med; 1996 Feb; 334(7):445-51. PubMed ID: 8552148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of gout.
    Emmerson BT
    Med J Aust; 1972 Mar; 1(10):475-8. PubMed ID: 5024419
    [No Abstract]   [Full Text] [Related]  

  • 12. Major unanswered questions in the clinical gout field.
    Stamp LK
    Curr Opin Rheumatol; 2017 Mar; 29(2):171-177. PubMed ID: 27926541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gout.
    Scott JT
    Br Med J; 1969 Aug; 3(5668):456-7. PubMed ID: 5811656
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in the therapy of gout.
    Gutman AB
    J Am Geriatr Soc; 1968 May; 16(5):499-504. PubMed ID: 4296544
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologic and biochemical basis for the treatment of gout and hyperuricemia.
    Mikkelsen WM; Robinson WD
    Med Clin North Am; 1969 Nov; 53(6):1331-47. PubMed ID: 4900718
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperuricemia and gout.
    Klinenberg JR
    Med Clin North Am; 1977 Mar; 61(2):299-312. PubMed ID: 323595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gout].
    Radi I
    Schweiz Med Wochenschr; 1970 Feb; 100(8):383-6. PubMed ID: 4946973
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperuricaemia and gout.
    Shipley M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.
    Roddy E; Zhang W; Doherty M
    Ann Rheum Dis; 2007 Oct; 66(10):1311-5. PubMed ID: 17504843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.